[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Reuters Legal [@ReutersLegal](/creator/twitter/ReutersLegal) on x 100.1K followers Created: 2025-07-21 17:40:16 UTC A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $XX million after finding that Revance's anti-wrinkle medication Daxxify infringed patents covering Allergan's rival drug Botox.  XXX engagements  [Post Link](https://x.com/ReutersLegal/status/1947350930132746366)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Reuters Legal @ReutersLegal on x 100.1K followers
Created: 2025-07-21 17:40:16 UTC
A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $XX million after finding that Revance's anti-wrinkle medication Daxxify infringed patents covering Allergan's rival drug Botox.
XXX engagements
/post/tweet::1947350930132746366